One Way to Spot Early Cognitive Decline? Medicare Wellness Visits
By Judy George Source Medpagetoday A Medicare annual wellness visit (AWV) was associated with greater recognition of mild cognitive impairment in...
Mental, Dementia, Parkinson’s disease
Depression, Anxiety Diagnoses Have Increased Among Young People
By Shannon Firth Source Medpagetoday Diagnoses of depression and anxiety among kids, teens, and young adults increased from 2017 to 2021, especially...
心理问题之源的慢性压力：危害，应对及抵抗之法
Sorry, this entry is only available in 中文.出處：花开心岸 慢性压力 Chronic Stress...
Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis
By Dimitrios S. Mysiris et al. Source NCBI Abstract Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease after...
New Extended-Release Parkinson’s Drug Approved
By Judy George Source Medpagetoday The FDA approved an oral extended-release formulation of levodopa and carbidopa known as IPX203 (Crexont) to...
Parkinson’s Dementia May Be Less Common Than Once Thought
By Judy George Source Medpagetoday Dementia in Parkinson's disease occurred less frequently or later in the disease course than previously reported,...
For Your Patients: What Is Alzheimer’s Disease?
By Crystal Phend Source Medpagetoday Alzheimer's disease is a progressive disease that affects the brain, initially causing mild memory problems and...
Expert Panel: Target These 14 Factors to Cut Dementia Incidence by Nearly Half
By John Gever Source Medpagetoday PHILADELPHIA -- The Lancet Commission on dementia prevention, intervention, and care has raised the number of...
To restrict or not to restrict? Practical considerations for optimizing dietary protein interactions on levodopa absorption in Parkinson’s disease
By C. Rusch et al. Source Nature Abstract Administration of levodopa for Parkinson’s disease (PD) has remained the most effective therapy for...
Alzheimer’s May Be Improved by Intensive Lifestyle Changes
By Judy George Source Medpagetoday Intensive lifestyle changes improved cognitive outcomes in a phase II trial of early Alzheimer's disease. In...